PennyTrader.com, announced today that it has initiated Profile Coverage of Spencer Pharmaceutical Inc. (Pinksheets: SPPH) on its exclusive penny stock alert service. Spencer Pharmaceutical Inc. is a public company specializing in the identification of new drug delivery applications. Spencer Pharmaceutical Inc. sent out news this morning announcing they have formalized the buyout offer with the Al-Dorra Group.
About
Spencer Pharmaceuticals Inc. is a public company specializing in the identification of new drug delivery applications. A global player in the biopharmaceutical market, Spencer has forged relationships with two highly respected laboratories located in Universities throughout the world. Their focus is on newly patented formulation of existing drugs from the incubation to the developmental stages or newly synthesized drugs able to cross the blood-brain barrier. The company's partners are experienced researchers providing years of research, now ready for the drug-development status.
Missions
Spencer is currently focusing on the development of 2 patented applications (ready for Human trial) in the treatment of Central Nervous System diseases and of Diabetes:
L’Institut National des Sciences Appliquées de Rouen (INSA Rouen) has discovered a new technology in the challenging area of drugs delivered to the Central Nervous System through an innovative approach that allows the crossing of the blood-brain barrier and dramatically reducing the side effects of drugs used for neurological diseases.
L’Universite du Québec à Montréal
(UQAM) has discovered how to control the release of existing therapeutics
molecules in order to increase their bio-availability and systemic efficacy.
The company's goal is to develop a portfolio of pro-drugs with the ability to outclass the current commercial drugs.
December
10 - Spencer Pharmaceutical Formalizes Buyout Offer With Al-Dorra
Spencer Pharmaceutical Inc. (Pinksheets:SPPH - News) announced today that is has formalized the buyout offer with the Al-Dorra Group as a successful results of meetings held in Montreal, Canada over the past week.
According
to the terms of the formal buyout offer, Al-Dorra will acquire Spencer
Pharmaceutical for $245 million USD on an all cash transaction to close on or
before March 17, 2011. As per the terms of the formal offer, Al-Dorra reserves
the right to acquire shares in the open market and Al-Dorra will deposit
$500,000 in the company's account to be used to pay legal fees, and expenses
associated with the ongoing business operations of Spencer Pharmaceutical.
For full a detailed quote and news visit: CLICK HERE
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader and affiliates have
been compensated ten thousand dollars by a third party (IAB Media) for this
current SPPH email promotion.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer Click Here
